Antimicrobial Resistance (AMR)
Anupama Verma
PhD Scholar, Division of Medicine, Indian Veterinary Research Institute, Izatnagar, Bareilly-243122, Uttar Pradesh
Abstract
Antimicrobial resistance (AMR) has emerged as one of the most formidable threats to modern veterinary and human medicine, steadily eroding the efficacy of drugs that have long safeguarded animal health, food security, and public well-being. India, with one of the world’s largest livestock populations and a rapidly expanding poultry sector, has become a hotspot for the emergence and dissemination of resistant pathogens. Misuse and overuse of antibiotics, limited diagnostic capacity, poor farm hygiene, and regulatory gaps have accelerated the spread of multidrug-resistant organisms across dairy farms, poultry enterprises, the environment, and the human population. Resistant strains such as extended-spectrum β-lactamase (ESBL) producing Enterobacter
iaceae, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant S. aureus (VRSA), fluoroquinolone-resistant enterobacteria, and colistin-resistant isolates have been increasingly documented in milk, meat, farm soils, and water channels. This essay provides an integrated examination of AMR in Indian livestock and poultry systems by merging and refining the content of two detailed manuscripts into a unified, coherent narrative. It discusses the scale of AMR, the factors responsible for its emergence, the molecular mechanisms involved, the animal–human–environment interface, the national regulatory landscape, strategies for prevention and containment, antimicrobial stewardship for field practice, and scientifically validated alternative approaches. The synthesis emphasizes that although several alternatives to antibiotics are promising, most cannot yet replace conventional antimicrobials entirely. Instead, they should be integrated as complementary strategies within a strong stewardship and biosecurity framework. A coordinated One Health approach that unites veterinarians, farmers, policymakers, researchers, and industries is essential to ensure sustainable livestock productivity, food safety, and public health.
Introduction: The escalating threat of Antimicrobial resistance
The introduction of Penicillin in 1928 revolutionized global medicine by enabling effective control of bacterial diseases that previously caused high mortality. Sir Alexander Fleming, the scientist who discovered Penicillin, warned in his 1945 Nobel lecture that bacteria could eventually develop resistance to antibacterial therapies if these medicines were misused. His warning materialized more rapidly than anticipated. By 2014, the World Health Organization confirmed that resistance has emerged against every new antibiotic ever introduced, highlighting the urgency of coordinated global action.
AMR is fundamentally a One Health problem, driven by the interconnectedness of humans, animals, and the environment. Resistant microbes share agricultural landscapes, market chains, food items, water systems, soils, and households. In India, the situation is especially concerning because the livestock and poultry sectors are expanding rapidly to meet the growing demand for milk, meat, and eggs. The intensification of these systems has been accompanied by widespread antibiotic use, often without veterinary prescription or diagnostic support. This has allowed resistant bacteria and resistance genes to proliferate in animal herds, hatcheries, retail markets, and the environment.
Antimicrobial resistance is now identified as a critical global health threat with profound political, health, and economic implications. The failure of standard treatments leads to prolonged illness and delays in recovery, which in turn increases the risk of transmitting resistant microorganisms to others. This escalation results in soaring healthcare costs and places a substantial economic burden on families and societies, threatening to undo decades of medical progress.
India’s designation as the “Epicenter of the AMR catastrophe” arises from repeated scientific observations. Resistance to critically important antimicrobials, such as those used for treating mastitis, respiratory diseases, and gastrointestinal infections in animals, has been identified across states and production systems. These trends not only undermine animal health and welfare but also contribute significantly to the human burden of AMR. Resistant pathogens from animals can move into the human population through direct contact, contaminated food, and environmental routes. This essay consolidates and harmonizes scientific insights from two comprehensive manuscripts into a single, detailed analysis of the AMR crisis in Indian livestock and poultry. It focuses on current resistance patterns, contributing factors, mechanisms of resistance, human–animal–environment interactions, regulatory actions by the Indian government, antimicrobial stewardship in veterinary practice, and modern alternatives to antibiotics that hold promise for the future.
Current status of AMR in Indian livestock and poultry
AMR has become deeply entrenched within Indian dairy and poultry production systems. Surveillance reports from dairy farms have consistently shown high levels of resistance among mastitis-causing bacteria. Several studies in West Bengal revealed that nearly half of the Gram-negative bacilli isolated from cow and buffalo milk samples produced extended-spectrum β-lactamases (ESBLs), making them resistant to third-generation cephalosporins that are critical to both human and veterinary medicine. In Gujarat, almost half of E. coli isolates exhibited resistance to oxytetracycline. Even more alarming is the emergence of vancomycin-resistant Staphylococcus aureus, a last-resort drug in human medicine, detected for the first time in bovine and goat milk in India. The prevalence of fluoroquinolone resistance in Enterobacteriaceae and the spread of methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci further illustrate the seriousness of the crisis. Recent detection of colistin-resistant strains in poultry farms adds an additional layer of concern due to colistin’s classification as a reserve antibiotic.
The poultry sector, an intensively managed component of India’s food production system, has emerged as a major reservoir of resistant bacteria and resistance genes. High resistance levels have been reported in avian pathogenic E. coli, Salmonella, Clostridium perfringens, and various staphylococcal species. In several poultry-dense regions, more than 70 percent resistance to fluoroquinolones and third-generation cephalosporins has been documented in common pathogens. Environmental assessments around farms have detected genes conferring resistance to carbapenems, macrolides, glycopeptides, and fluoroquinolones, including qnr, blaCTX-M, blaNDM, and mcr. These findings indicate that the poultry environment functions not merely as a reservoir but as an active amplifier of resistance genes.
Environmental contamination acts as a crucial driver of resistance circulation. Antibiotics excreted through urine and feces enter agricultural soils, canals, and farm drainage systems, where they promote the survival and multiplication of resistant bacteria. Manure used for crop fertilization creates a feedback loop, reintroducing resistance genes into the food chain and creating a continuous cycle of contamination. Slaughterhouse wastewater, dairy effluents, and untreated sewage containing resistant bacteria further accelerate dissemination into wider ecosystems.
Drivers of AMR in livestock and poultry
The emergence and spread of AMR in India’s livestock and poultry systems are driven by a combination of human behaviors, economic pressures, inadequate infrastructure, and microbial adaptation. One of the most important contributors is the irrational use of antibiotics. In many rural areas, farmers administer antibiotics without a prescription, often using leftover tablets or human medicinal formulations. Treatment is frequently initiated without any diagnostic evaluation, and courses are discontinued prematurely once clinical signs reduce. Repetition of the same drug for recurrent illnesses is common, as is the perception that “stronger medicines” guarantee faster recovery. Over-the-counter availability of antibiotics further aggravates the issue, enabling unrestricted access to potent drugs.
Poor farm management and hygiene practices contribute heavily to disease occurrence and, consequently, to repeated antibiotic use. In dairy farms, substandard milking hygiene, lack of teat sanitization, inadequate bedding, and failure to identify subclinical mastitis allow infections to flourish. In poultry units, high stocking densities, inadequate ventilation, poor litter management, and violations of biosecurity norms lead to outbreaks that compel farmers to resort to mass medication. Many poultry producers continue to use antimicrobials prophylactically, despite national guidelines discouraging non-therapeutic antibiotic use.
A widespread lack of awareness regarding withdrawal periods often leads to the sale of milk, meat, and eggs from animals undergoing antibiotic treatment. This practice introduces drug residues directly into the food chain, posing risks to consumers while selecting for resistant bacteria within the human gut. Compounding these issues is the limited availability of diagnostic facilities. Most field veterinarians do not have access to culture and sensitivity testing, and molecular diagnostic tools are limited to specialized laboratories. As a result, empirical treatment becomes the norm, leading to repeated use of broad-spectrum antimicrobials.
Socioeconomic factors also play a significant role. Many small-scale farmers operate on thin profit margins, making preventive healthcare and veterinary consultation appear financially burdensome. As a result, they frequently seek medical advice only during severe disease episodes, by which time more aggressive antibiotic therapy is required. Limited veterinary manpower in rural areas further restricts access to qualified guidance, creating conditions in which irrational drug use flourishes.
Mechanisms of antimicrobial resistance
Bacteria employ diverse molecular strategies to survive exposure to antimicrobial agents. Understanding these mechanisms helps in identifying effective control strategies. Resistance can be either intrinsic or acquired. Intrinsic resistance refers to natural characteristics inherent to certain bacterial species, such as the outer membrane barrier of Gram-negative bacteria. Acquired resistance, on the other hand, emerges through genetic mutation or horizontal gene transfer.
One of the most widespread resistance mechanisms is drug inactivation, in which bacteria produce enzymes that chemically alter or degrade antibiotics. β-lactamases such as ESBLs, AmpC enzymes, and carbapenemases, including NDM-1 and KPC, hydrolyze β-lactam antibiotics, rendering them ineffective. Aminoglycoside resistance frequently arises through enzymatic modification by acetyltransferases, phosphotransferases, or nucleotidyltransferases. Another key mechanism is target modification. In methicillin-resistant S. aureus, the bacteria alter penicillin-binding proteins, reducing the affinity of β-lactams. Fluoroquinolone resistance often results from mutations in DNA gyrase and topoisomerase IV. Macrolide resistance may result from methylation of the 23S rRNA, preventing drug binding.
Efflux pumps are membrane proteins that actively expel antibiotics from the bacterial cell, preventing drug accumulation to lethal levels. These pumps confer resistance to tetracyclines, macrolides, and fluoroquinolones. Reduced permeability, especially among Gram-negative bacteria, results from porin loss or modification, decreasing the entry of antibiotics. Some bacteria develop resistance through metabolic bypass pathways, compensating for the inhibitory effect of antimicrobial agents.
Resistance genes often spread through horizontal gene transfer. Conjugation, facilitated by plasmids and integrons, allows rapid dissemination of genes conferring resistance to β-lactams, aminoglycosides, colistin, and other drugs. Transformation, the uptake of naked DNA from the environment, enables bacteria to acquire genetic material from lysed cells. Transduction, mediated by bacteriophages, transfers resistance genes between bacteria.
One health perspective: The Animal–Human–Environment Interface
AMR is not confined to the animal population; it exists in a dynamic continuum involving humans and the environment. Resistant bacteria from livestock reach the human population through multiple pathways. Direct contact with animals, especially in dairy farms, poultry houses, and slaughter facilities, exposes workers to resistant microbes. Consumption of raw or inadequately cooked milk, meat, and eggs contaminated with resistant bacteria can also serve as a transmission route. Environmental exposure plays a crucial role, as manure and wastewater laden with resistant organisms contaminate soil, water bodies, and crops. This contamination cycles back into farms when animals ingest polluted feed or water.
Genomic studies have shown that some livestock-associated MRSA strains originally evolved from methicillin-sensitive human strains, indicating a bidirectional flow of resistance. Several foodborne pathogens isolated from retail stores have been genetically similar to strains found in farm animals, despite consumers having no direct contact with livestock. This demonstrates that the food chain is a major conduit for AMR transmission.
Environmental resistomes, consisting of resistance genes in soil, water, and sediments, act as reservoirs for both pathogenic and non-pathogenic bacteria. Intensive use of antibiotics in agriculture and aquaculture enriches these resistomes, enabling resistance genes to persist for long periods even after antibiotic use has ceased. Through manure application, wastewater irrigation, and contaminated runoff, the environment becomes a powerful amplifier of AMR, ultimately influencing both animal and human health.
National regulatory and policy framework in India
Recognizing the gravity of the AMR crisis, India has implemented several policy interventions over the past decade. The Jaipur Declaration of 2011 marked an early regional commitment to addressing AMR in the WHO South-East Asia Region. In 2012, the National Programme on the Containment of AMR was launched, primarily focusing on human health but laying the groundwork for veterinary integration. The adoption of the National Action Plan on AMR (NAP-AMR) in 2017 represented a major milestone, committing India to a One Health approach and establishing surveillance networks across states. FSSAI established residue limits for veterinary drugs in meat and milk, while the government enforced stronger regulations on the use of critical antimicrobials. A landmark decision was taken in 2019 with the prohibition of colistin manufacture, sale, and use in food-producing animals, recognizing its critical importance in human medicine.
Building on these foundational efforts, the government has recently intensified its response. In New Delhi on 18th Dec, Union Health and Family Welfare Minister J.P. Nadda launched the second version of the National Action Plan on Antimicrobial Resistance (NAP-AMR 2.0) for the period 2025-29. Emphasizing that AMR is a major public health concern that can only be addressed through collective action, Mr. Nadda highlighted that AMR poses significant risks, particularly in surgical procedures, cancer treatment, and other critical healthcare interventions. The overuse and misuse of antibiotics has unfortunately become common practice, underscoring the urgency of corrective measures. NAP-AMR 2.0 specifically addresses gaps identified in the first version of the plan by increasing the ownership of AMR-related efforts, strengthening inter-sectoral coordination, and ensuring stronger engagement with the private sector.
The development of Standard Veterinary Treatment Guidelines (SVTGs) in 2025 by the Department of Animal Husbandry and Dairying further supports these policy goals, providing veterinarians with standardized protocols for rational antimicrobial use in common diseases. These guidelines categorize antimicrobials based on therapeutic importance, outlining when they may be used and under what conditions. Despite regulatory progress, implementation remains inconsistent due to weak enforcement, limited veterinary manpower, and low awareness among farmers.
Strategies for prevention and containment of AMR
Effective control of AMR requires a comprehensive and integrated approach that addresses prevention, diagnosis, treatment, and monitoring. Improving farm hygiene and biosecurity is fundamental. Clean housing, proper ventilation, quality feed, and clean water reduce the incidence of infections that require antibiotic treatment. In dairy farms, hygienic milking practices, pre- and post-teat dipping, dry cow therapy, and regular screening for subclinical mastitis substantially reduce antibiotic dependence. In poultry units, implementing all-in/all-out systems, restricting farm access, disinfecting equipment, and ensuring adequate litter management are key elements of a sustainable disease prevention strategy.
Rational antimicrobial use lies at the heart of AMR containment. Veterinarians must prescribe antibiotics only when absolutely necessary, preferably after obtaining diagnostic confirmation. Narrow-spectrum antimicrobials should be prioritized over broad-spectrum alternatives, and treatment should strictly follow recommended dosage, duration, and withdrawal periods. Preventive use of antimicrobials should be minimized, and reliance on critically important antimicrobials should be avoided unless no alternatives exist.
Surveillance plays a crucial role in understanding resistance trends and guiding policy decisions. Active participation in networks such as ICAR-NIVEDI’s INFAAR and state veterinary diagnostic laboratories enables timely identification of resistance patterns. Farmer education is equally important. When farmers understand the risks associated with antibiotic misuse and the benefits of good farm management and vaccination, compliance with veterinary recommendations improves significantly. Veterinary public health interventions, such as routine residue monitoring at milk collection centers and ensuring hygienic slaughtering practices, further safeguard food safety.
Alternative management strategies to reduce antibiotic dependence
Given the limitations and risks associated with antibiotic use, the exploration of alternative strategies has gained considerable momentum. Vaccination remains one of the most effective preventive tools, reducing the incidence of infectious diseases and lowering the need for antibiotic intervention. Recombinant vaccines such as Gavac and Tick GUARD for Rhipicephalus microplus in cattle and EG95 for hydatidosis in sheep and goats offer disease control without creating selective pressure for antibiotic resistance.
Probiotics, prebiotics, and synbiotics enhance gut health by promoting beneficial microbial populations that outcompete pathogenic bacteria. These supplements improve digestion, enhance immunity, and reduce the risk of enteric infections. Phage therapy offers a targeted approach to bacterial control. Bacteriophages, viruses that infect bacteria, selectively eliminate harmful pathogens without disturbing beneficial flora. Their use has shown promise in managing Listeria contamination and treating mastitis and enteritis.
Antimicrobial peptides (AMPs), including bacteriocins such as nisin, have broad-spectrum activity and disrupt bacterial membranes through physical mechanisms that are difficult for bacteria to circumvent. These peptides have found application in teat dips and food preservation. Phytocompounds derived from plants such as guava, cinnamon, and fenugreek contain alkaloids, phenolics, and terpenoids with antimicrobial and immunomodulatory effects. Nanoparticles, particularly zinc oxide and silver nanoparticles, exhibit antimicrobial activity through oxidative stress and cell membrane disruption, offering another promising avenue.
Cytokines and immunostimulants enhance the animal’s innate immune system. Interleukins such as IL-1 and IL-2 have been used experimentally to boost mammary immunity against S. aureus. CpG-based immunostimulants like Zelnate strengthen immune responses against respiratory pathogens. Although these alternative strategies provide encouraging results, they cannot yet fully replicate the broad-spectrum efficacy of antibiotics. They are best positioned as complementary tools within a larger stewardship framework.
Antimicrobial stewardship (AMS) in field veterinary practice
Antimicrobial stewardship in veterinary medicine is essential for preserving antimicrobial efficacy while ensuring responsible use. Stewardship requires veterinarians to exercise professional responsibility by basing treatment decisions on evidence, diagnostics, and established guidelines rather than convenience or farmer pressure. A fundamental principle of stewardship is the optimal selection of drug, dose, duration, and route. Diagnostics play a pivotal role. Even simple point-of-care tests such as the California Mastitis Test, lateral flow assays, and strategic use of laboratory culture can sharply reduce unnecessary antibiotic use. Empirical treatment should be reserved for situations where immediate action is required and diagnostic delay would endanger animal welfare.
Field veterinarians must also evaluate farm management factors contributing to disease and encourage corrective measures. Good nutrition, vaccination, stress reduction, and hygiene reduce illness and, in turn, reduce antibiotic usage. Maintaining accurate treatment records allows veterinarians to track patterns of drug use and disease recurrence, enabling them to refine therapeutic strategies.
In resource-limited settings, practical stewardship involves balancing ideal principles with ground realities. Veterinarians must educate farmers about the importance of completing treatment courses, adhering to withdrawal periods, and avoiding over-the-counter medication. Collaboration with government departments and participation in surveillance networks strengthen the collective ability to monitor and tackle AMR. Ultimately, stewardship is not a single intervention but a continuous process of responsible clinical decision-making that promotes animal welfare, food safety, and public health.
Conclusion
Antimicrobial resistance poses a profound threat to India’s livestock and poultry sectors and to the broader goals of animal health, food safety, and public health. The widespread presence of resistant pathogens such as ESBL-producing E. coli, MRSA, VRSA, fluoroquinolone-resistant organisms, and colistin-resistant strains illustrates the severity of the challenge. The drivers of AMR, ranging from inappropriate antibiotic use to poor farm hygiene and environmental contamination, are deeply embedded within current production systems, making the problem both urgent and complex.
While alternative strategies including vaccines, phage therapy, probiotics, phytochemicals, antimicrobial peptides, nanoparticles, and immunostimulants offer significant promise, they cannot presently replace antibiotics entirely. The most rational and sustainable approach therefore lies in integrating these alternatives with strong antimicrobial stewardship, improved diagnostics, enhanced biosecurity, and strict regulation of antibiotic use.
A collaborative One Health approach is essential. Veterinarians must lead stewardship at the ground level; farmers must adopt better management practices; policymakers must strengthen surveillance and enforcement; and scientists must continue developing innovative diagnostic and therapeutic tools. With sustained commitment and coordinated action, India can address the AMR challenge effectively, ensuring healthier animals, safer food, and a more secure future for both human and veterinary medicine.
